We are Imperial College Healthcare
Imperial College Healthcare NHS Trust provides acute and specialist healthcare for over one million people every year. We particularly serve the local communities in the eight boroughs that form the North West London Integrated Care System. Formed in 2007, we are one of the largest NHS trusts in the country, with more than 14,500 staff.
Our five hospitals in central and west London – Charing Cross, Hammersmith, Queen Charlotte’s & Chelsea, St Mary’s and The Western Eye – have a long track record in research and education, influencing care and treatment nationally and worldwide. We are developing a growing range of integrated and digital care services and offer private healthcare in dedicated facilities on all our sites, including at the Lindo Wing at St Mary’s Hospital.
Find out more about how we're run
Building better hospitals
Imperial College Healthcare NHS Trust has formally submitted its strategic outline case for the redevelopment of St Mary’s Hospital in Paddington. The hospital, together with the Trust’s Charing Cross and Hammersmith hospitals – are included in the 40 new hospitals the government has committed to build by 2030 as part of the government’s wider Health Infrastructure Plan.
Upcoming event
-
North West London Acute Provider Collaborative - Board in Common meeting
09:00 - 11:00
tbc -
North West London Acute Provider Collaborative - Board in Common meeting
13:00 - 17:00
tbc -
North West London Acute Provider Collaborative - Board in Common meeting
09:00 - 13:00
tbc -
North West London Acute Provider Collaborative - Board in Common meeting
13:00 - 17:30
tbc
Latest news See all news
-
Read the full story
Antimicrobial resistance: securing the future
The discovery of penicillin in 1928 at St Mary’s Hospital marked the beginning of the antibiotic revolution and earned Sir Alexander Fleming a Nobel Prize. Almost a century on, these medicines have saved countless lives globally by killing bacteria…
-
Read the full story
UK Government backs Fleming Centre to fight threat of drug resistant infections
The UK Government has committed £5million in seed funding to support a joint initiative to fight antimicrobial resistance.
-
Read the full story
UK medicines regulator approves world-first gene-editing treatment for blood disorders
The UK has become the first country in the world to approve gene editing as a potential cure for two inherited blood disorders.